eli lilly oral glp-1 to seek approval of new weight-loss drug this year Eli Lilly Gets Speedy FDA

Although the name can be a bit misleading, Glucagon-Like Peptide-1 agonists (GLP-1s) are diabetes drugs that mimic the natural gut hormone GLP-1, which, unlike glucagon, decreases your blood sugar and reduces glucagon, especially after meals

A 2021 study found that combining exercise with GLP-1 medication led to greater healthy weight loss than using either approach on its own

241 ZaitoneS

If GLP-1 receptor modulation proves effective in reducing cravings and relapse risk, it could inaugurate an entirely new class of addiction therapeutics rooted in metabolic-neuroendocrine mechanisms

In addition, its good to have more evidence to be able to say to patients, If you lose weight, all these things will improve, he said, including sleep apnea symptoms

Bernice A